0.8521
Prelude Therapeutics Inc 주식(PRLD)의 최신 뉴스
Buy Signal for Prelude Therapeutics Incorporated Stock Key Technical Indicators to WatchMarket Forecast Summary Over Multi-Year Period - Newser
SRx Health Solutions Inc. recovery potential after sell offPrice Action Summary and Entry Strategy Guide - Newser
Using data models to predict Prelude Therapeutics Incorporated stock movementFree Growth Focused Entry Plan Suggestions - Newser
What is the dividend policy of Prelude Therapeutics Incorporated stockBuild your wealth with consistent stock growth - jammulinksnews.com
What makes Prelude Therapeutics Incorporated stock price move sharply Entry Timing Tracker with Alert Accuracy - Newser
Why Prelude Therapeutics Incorporated stock attracts strong analyst attentionPredictive Screener for Daily Trade Watch - Newser
Is it the right time to buy Prelude Therapeutics Incorporated stockDiscover stocks with strong growth potential - jammulinksnews.com
Prelude Therapeutics Incorporated Stock Performance After Earnings: Historical InsightsWeekly Big Movers - Newser
What makes Prelude Therapeutics Incorporated stock price move sharplyFree Access to Community - metal.it
Prelude Therapeutics (NASDAQ:PRLD) Trading 2% Higher – Time to Buy? - Defense World
What drives Prelude Therapeutics Incorporated stock priceUnmatched profit growth - PrintWeekIndia
Is Prelude Therapeutics Incorporated a good long term investmentSkyrocketing investment returns - PrintWeekIndia
What analysts say about Prelude Therapeutics Incorporated stockRapid wealth accumulation - Autocar Professional
Will Prelude Therapeutics Incorporated stock split in the near futureExplosive trading opportunities - jammulinksnews.com
Prelude Therapeutics Advances Cancer Treatment with PRT7732 Study - TipRanks
Prelude Therapeutics Incorporated Stock Analysis and ForecastExplosive capital gains - jammulinksnews.com
what makes prelude therapeutics incorporated stock price move sharplyFree Investment Community - Newser
Is Prelude Therapeutics Incorporated stock a good hedge against inflation10x Return With Managed Risk - Newser
How Prelude Therapeutics Incorporated stock performs during market volatilityFree Smart Investment Opportunities - Newser
Prelude Therapeutics’ PRT7732 Study: A Potential Game-Changer for SMARCA4 Mutations - TipRanks
Prelude Therapeutics Advances PRT3789 in Phase 1 Study for SMARCA4 Mutant Tumors - TipRanks
자본화:
|
볼륨(24시간):